Search Results - Rinki Deo

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response by Marc-Kendy Paul, Manish Choudhary, Amy Heaps, Rinki Deo, Daniela Moisi, Kelley Gordon, John Mellors, Carlee Moser, Paul Klekotka, Alan Landay, Judith Currier, Joseph Eron, Kara Chew, Davey Smith, Scott Sieg, Urvi Parikh, Jonathan Li

    Published in Pathogens and Immunity (2024-08-01)
    Get full text
    Article


  2. 2

    Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibod... by Urvi Parikh, Amy Heaps, Daniela Moisi, Kelley Gordon, John Mellors, Manish Choudhary, Rinki Deo, Carlee Moser, Paul Klekotka, Alan Landay, Judith Currier, Joseph Eron, Kara Chew, Davey Smith, Jonathan Li, Scott Sieg, ACTIV-2/A5401 Study Team

    Published in Pathogens and Immunity (2024-08-01)
    Get full text
    Article


  3. 3

    Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody. by Tin Phan, Carolin Zitzmann, Kara W Chew, Davey M Smith, Eric S Daar, David A Wohl, Joseph J Eron, Judith S Currier, Michael D Hughes, Manish C Choudhary, Rinki Deo, Jonathan Z Li, Ruy M Ribeiro, Ruian Ke, Alan S Perelson, ACTIV-2/A5401 Study Team

    Published in PLoS Pathogens (2024-04-01)
    Get full text
    Article


  4. 4

    Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies by Rachel A. Bender Ignacio, Kara W. Chew, Carlee Moser, Judith S. Currier, Joseph J. Eron, Arzhang Cyrus Javan, Mark J. Giganti, Justin Ritz, Michael Gibbs, Hervé Tchouakam Kouekam, Mark T. Esser, Eric S. Daar, Manish Choudhary, Rinki Deo, Courtney V. Fletcher, Jonathan Z. Li, Michael D. Hughes, Davey Smith, David Alain Wohl

    Published in iScience (2025-03-01)
    Get full text
    Article


  5. 5

    Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19 by Kara W. Chew, Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs, Justin Ritz, Mark Giganti, Arzhang Cyrus Javan, Yijia Li, Manish C. Choudhary, Rinki Deo, Carlos Malvestutto, Paul Klekotka, Karen Price, Ajay Nirula, William Fischer, Veenu Bala, Ruy M. Ribeiro, Alan S. Perelson, Courtney V. Fletcher, Joseph J. Eron, Judith S. Currier, ACTIV-2/A5401 Study Team, Michael D. Hughes, Davey M. Smith

    Published in Nature Communications (2022-08-01)
    Get full text
    Article


  6. 6

    Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected Patien... by Sara V. Patel, Brooke M. Leeman, Patricia J. Botros, Joanna Folta, Dhiman Shahid, Anya I. Rocque, Andrew S. Joyal, Joseph A. Vecchio, Eliza Passell, Dessie Tien, Zahra Reynolds, Karry Su, Tammy D. Vyas, Jatin M. Vyas, Emory Abar, Mamadou Barry, Andrew Alexandrescu, Zachary Wallace, Jeffrey M. DaCosta, Manish C. Choudhary, Trevor J. Tamura, Gregory E. Edelstein, Yijia Li, Rinki Deo, Jeffrey A. Sparks, Julie Boucau, Owen T. Glover, Amy K. Barczak, Jacob Lemieux, Mark J. Siedner, Jonathan Z. Li, Ismael Ben Fofana

    Published in Vaccines (2025-09-01)
    Get full text
    Article


Search Tools: